Engineers Gate Manager LP Compugen LTD Transaction History

Engineers Gate Manager LP

  • $4.27 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$0.58 - $1.2 $8,423 - $17,427
14,523 New
14,523 $10,000
Q4 2021

Feb 14, 2022
SELL
$4.09 - $7.16 $62,523 - $109,454
-15,287 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$5.8 - $8.02 $88,664 - $122,601
15,287 New
15,287 $91,000
Q4 2020

Feb 16, 2021
SELL
$12.07 - $17.95 $425,129 - $632,234
-35,222 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$14.16 - $19.45 $498,743 - $685,067
35,222 New
35,222 $572,000

Others Institutions Holding CGEN

# of Institutions
73
Shares Held
13.3M
Call Options Held
191K
Put Options Held
135K
View Full List

About COMPUGEN LTD

CGEN Quotes by TradingView
  • Ticker CGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,600
  • Market Cap $142M
  • Description
  • Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...
More about CGEN
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email